内微生物群:对癌症发病,进展和治疗的影响
Jinmei Wu1, Pengfei Zhang1, Wuxuan Mei2
1Department of Medical Laboratory, Shenzhen Longhua District Central Hospital, Shenzhen, China.
Frontiers in immunology
|January 31, 2024
概括
本综述探讨了内微生物群在癌症发展和进展中的作用. 它强调它们对瘤细胞和免疫系统的影响,并讨论治疗策略.
科学领域:
- 在瘤学瘤学.
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
背景情况:
- 关于微生物组和癌症的研究主要集中在肠道微生物组.
- 瘤微环境 (TME) 中瘤内微生物群的作用尚未得到研究.
- 内微生物会影响癌细胞的特性和免疫反应.
研究的目的:
- 审查内微生物群与癌症之间的复杂关系.
- 阐明内微生物群对癌症发病和进展的贡献.
- 探索与内微生物群相关的治疗进展.
主要方法:
- 关于内微生物群和癌症现有研究的文献综述.
- 对研究癌症中内微生物群的机制的分析.
- 综合了针对内微生物群的治疗策略的信息.
主要成果:
- 内微生物群显著影响癌细胞行为和瘤免疫微观环境.
- 这些微生物在各种癌症的发展和进展中起着至关重要的作用.
- 新兴的治疗方法利用内微生物群来治疗癌症.
结论:
- 内微生物群是瘤微环境中的关键参与者,对癌症有重大影响.
- 了解这些相互作用对于开发新型癌症疗法至关重要.
- 对内微生物群的机制和治疗潜力的进一步研究是有必要的.
更多相关视频
09:52A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
Published on: September 20, 2016
10.3K
08:26Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
Published on: March 24, 2013
25.0K
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
